Integrated biomarker panels provide more complete insights into mechanism-specific therapeutic responses in rheumatoid arthritis
New markers could help predict how rheumatoid arthritis drugs work
This narrative review evaluates conventional and emerging biomarkers for predicting treatment response and resistance in patients with rheum…
Doctors are looking at new biological markers to better predict which treatments will actually work for people with rheumatoid arthritis.
JAK and IL-6 inhibitors outperform TNF inhibitors for activity limitation in rheumatoid arthritis
Specific Biologic Drugs Show Better Results for Rheumatoid Arthritis
This meta-analysis of 99 studies evaluated patient-reported outcomes (PROs) in patients with rheumatoid arthritis treated with b/tsDMARDs. T…
New analysis shows that certain types of biologic drugs may better reduce activity limits and improve mental health for people with rheumato…
Baricitinib showed limited efficacy in pediatric JIA-uveitis patients refractory to methotrexate or biologics at week 24
New Hope for Kids with Stubborn Eye Inflammation
This open-label, active-controlled phase-3 multicenter trial enrolled 30 pediatric patients with juvenile idiopathic arthritis-associated uv…
A new drug shows early promise for children with stubborn eye inflammation who didn't respond to standard treatments, offering hope when oth…